276 related articles for article (PubMed ID: 21320556)
21. A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication.
Dansako H; Ikeda M; Abe K; Mori K; Takemoto K; Ariumi Y; Kato N
Virus Res; 2008 Oct; 137(1):72-9. PubMed ID: 18602954
[TBL] [Abstract][Full Text] [Related]
22. Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype.
Satoh S; Mori K; Ueda Y; Sejima H; Dansako H; Ikeda M; Kato N
PLoS One; 2015; 10(2):e0118313. PubMed ID: 25699517
[TBL] [Abstract][Full Text] [Related]
23. Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha.
Naka K; Ikeda M; Abe K; Dansako H; Kato N
Biochem Biophys Res Commun; 2005 May; 330(3):871-9. PubMed ID: 15809077
[TBL] [Abstract][Full Text] [Related]
24. Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA.
Sejima H; Mori K; Ariumi Y; Ikeda M; Kato N
Virus Res; 2012 Jul; 167(1):74-85. PubMed ID: 22579597
[TBL] [Abstract][Full Text] [Related]
25. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line.
Kato N; Mori K; Abe K; Dansako H; Kuroki M; Ariumi Y; Wakita T; Ikeda M
Virus Res; 2009 Dec; 146(1-2):41-50. PubMed ID: 19720094
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
McHutchison JG; Shiffman ML; Cheung RC; Gordon SC; Wright TL; Pottage JC; McNair L; Ette E; Moseley S; Alam J
Antivir Ther; 2005; 10(5):635-43. PubMed ID: 16152757
[TBL] [Abstract][Full Text] [Related]
27. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.
Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J
Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546
[TBL] [Abstract][Full Text] [Related]
28. Serum-free cell culture system supplemented with lipid-rich albumin for hepatitis C virus (strain O of genotype 1b) replication.
Abe K; Ikeda M; Ariumi Y; Dansako H; Kato N
Virus Res; 2007 May; 125(2):162-8. PubMed ID: 17267063
[TBL] [Abstract][Full Text] [Related]
29. [Replication of hepatitis C virus genome].
Kato N
Uirusu; 2008 Dec; 58(2):191-8. PubMed ID: 19374197
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
31. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
[TBL] [Abstract][Full Text] [Related]
32. Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems.
Cagnon L; Wagaman P; Bartenschlager R; Pietschmann T; Gao T; Kneteman NM; Tyrrell DL; Bahl C; Niven P; Lee S; Simmen KA
J Virol Methods; 2004 Jun; 118(1):23-31. PubMed ID: 15158065
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture.
Yano M; Ikeda M; Abe K; Dansako H; Ohkoshi S; Aoyagi Y; Kato N
Antimicrob Agents Chemother; 2007 Jun; 51(6):2016-27. PubMed ID: 17420205
[TBL] [Abstract][Full Text] [Related]
34. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.
Ariumi Y; Kuroki M; Abe K; Dansako H; Ikeda M; Wakita T; Kato N
J Virol; 2007 Dec; 81(24):13922-6. PubMed ID: 17855521
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
36. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
[TBL] [Abstract][Full Text] [Related]
37. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of bovine viral diarrhea virus in vitro by xanthohumol: comparisons with ribavirin and interferon-alpha and implications for the development of anti-hepatitis C virus agents.
Zhang N; Liu Z; Han Q; Chen J; Lou S; Qiu J; Zhang G
Eur J Pharm Sci; 2009 Nov; 38(4):332-40. PubMed ID: 19720145
[TBL] [Abstract][Full Text] [Related]
39. Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations.
Wittine K; Stipković Babić M; Makuc D; Plavec J; Kraljević Pavelić S; Sedić M; Pavelić K; Leyssen P; Neyts J; Balzarini J; Mintas M
Bioorg Med Chem; 2012 Jun; 20(11):3675-85. PubMed ID: 22555152
[TBL] [Abstract][Full Text] [Related]
40. Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.
Panigrahi R; Chandra PK; Ferraris P; Kurt R; Song K; Garry RF; Reiss K; Coe IR; Furihata T; Balart LA; Wu T; Dash S
J Virol; 2015 Jan; 89(1):626-42. PubMed ID: 25339775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]